2h-imidazol-4-amine compounds and use thereof as bace inhibitors

The invention relates to 2H-imidazol-4-amine compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of the compounds for treating Alphabeta-related pathologies such as Down's syndrome, beta-amyloid angiopathy, Alzheimer's disease, memory lo...

Full description

Saved in:
Bibliographic Details
Main Authors KOLMODIN KARIN, SOEDERMAN PETER, SANDBERG LARS, CSJERNYIK GABOR, SWAHN BRITT-MARIE, KARLSTROEM SOFIA, OEHBERG LISELOTTE
Format Patent
LanguageEnglish
Published 04.03.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to 2H-imidazol-4-amine compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of the compounds for treating Alphabeta-related pathologies such as Down's syndrome, beta-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration methods of therapy, and pharmaceutical compositions containing such compounds. In a formula (I), A is -O- or -CH2-, and n is 0 or 1.
Bibliography:Application Number: CN2013832891